Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 12.65
-0.35 (-2.69%)
Aug 21, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 13.79 billion as of August 21, 2026. Its market cap has increased by 35.34% in one year.
Market Cap
13.79B
Enterprise Value
12.33B
Revenue
1.53B
Ranking
n/a
PE Ratio
99.35
Stock Price
12.65
ChartMarket Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 13.79B, an increase of 1,310.36%. That is a compound annual growth rate of 10.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 13.79B | -16.28% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 16.16B |
| Sino Biological,Inc. | 16.00B |
| HitGen | 15.51B |
| GemPharmatech | 15.01B |
| Anhui Anke Biotechnology (Group) | 14.95B |
| Mabwell (Shanghai) Bioscience | 14.48B |
| Shanghai Medicilon | 13.22B |
| Nanjing Vazyme Biotech | 12.53B |